CDSCO (India)
NOTICE
FAQs on Drugs and Cosmetics (Compounding of Offences) Rules, 2025
Published: 1/1/2026Detected: 9/11/2026
Summary preview
Clarifies how the Drugs and Cosmetics (Compounding of Offences) Rules, 2025 are expected to be applied in practice, focusing on regulatory compliance expectations for compounding of offences under CDSCO.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
safety
labeling
clinical
#compounding of offences
#Drugs and Cosmetics
#CDSCO
#compliance
#pharmaceutical regulation
Official Source Document Source Verified
Access the original document directly from INDIA CDSCO.
More from CDSCO (India)
- Indiscriminate use of painkillers (NSAIDs), antibiotics and associated risk of Chronic Kidney Disease9/22/2026
- LIST OF REGISTRED BA-BE STUDY CENTRE & BIO-ANALYTICAL LABORATORY under NDCT Rules 20199/18/2026
- Public Health alert against the use of unauthorised Cosmetics Products9/14/2026
- 2026.09.08 G.S.R. 791(E)_Draft notification for amendment in the Drugs Rules 1945 regarding mandatory installation of CCTV surveillance system at sales premises9/8/2026
- Drug Regulatory and Law Enforcement Agencies Intensify Coordinated Action Against Illegal Manufacture and Distribution of Misbranded Drugs9/5/2026